FBLN2

protein-coding

fibulin 2, the group of Fibulins

Gene summary

This gene encodes an extracellular matrix protein, which belongs to the fibulin family. This protein binds various extracellular ligands and calcium. It may play a role during organ development, in particular, during the differentiation of heart, skeletal and neuronal structures. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

MANE transcript

NM_001004019.2

Inheritance

AD

ClinVar variants

U:242B:14

Top phenotype

Pulmonary arterial hypertension

gnomAD constraint

pLI —, LoF o/e 0.35

Max pathogenic AF

—

Genomic locus

chr3:13,549,125-13,638,422

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~89.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0005453

Submitter: ClinGen

*FBLN2* was first reported in relation to autosomal dominant congenital heart disease in 2012 (Ackerman et al., PMID:23040494). One proband with a truncating variant reported in a publication was included in this curation (PMID: 33084842). This gene-disease relationship is supported by expression studies and biochemical function study (PMIDs: 7851641, 11507771, 21743496). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 11/27/2023 (SOP Version 10)

pulmonary arterial hypertensionLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0015924

Submitter: ClinGen

FBLN2 was first reported in relation to autosomal dominant pulmonary arterial hypertension (PAH) in 2021 (Zhu et al., PMID: 33971972) in a case control study. Out of a cohort of 1647 idiopathic PAH cases, 3 rare predicted deleterious missense variants were identified in 6 unrelated individuals with one variant recurrent in four individuals. The relationship between FBLN2 and PAH is also supported by expression evidence from GTEx bulk tissue expression. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen PH Gene Curation Expert Panel on 8/30/2022 (SOP Version 9).

pulmonary arterial hypertensionLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0015924

Submitter: PanelApp Australia

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to FBLN2 variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 237
not providedTotal: 6
Pulmonary arterial hypertensionTotal: 1
Erythrocytosis, familial, 4Total: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001004019.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
3
clinvar
3
clinvar
8
missense
236
clinvar
6
clinvar
2
clinvar
244
nonsense
2
clinvar
2
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total0024295256
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 52 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001004019.2RefSeqNP_001004019.117MANE Select
ENST00000404922.8EnsemblENSP00000384169.317MANE Select
NM_001165035.2RefSeqNP_001158507.117Standard
NM_001998.3RefSeqNP_001989.216Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Extracellular matrix organization
  • Molecules associated with elastic fibres
  • Elastic fibre formation

Biological Process

  • positive regulation of cell-substrate adhesion
  • extracellular matrix organization

Molecular Function

  • extracellular matrix structural constituent
  • calcium ion binding
  • extracellular matrix constituent conferring elasticity
  • extracellular matrix binding

Cellular Component

  • extracellular region
  • extracellular matrix
  • collagen-containing extracellular matrix
  • extracellular vesicle

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000404922
Coding exons
17
Length
106099
Individuals with no LoFs
124641
Homozygous LoFs
0
Heterozygous LoFs
37
Defined
124678
p
0.000148
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.7667057650.9220.00005047887
Missense (PolyPhen)257336.920.76283615
Synonymous0.6243203350.9570.00002482450
Loss of Function4.381953.60.3540.00000282591

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000260.00026rare
Latino/Admixed American0.000120.00012rare
Ashkenazi Jewish0.000200.00020rare
East Asian0.000120.00011rare
Finnish0.000240.00023rare
European (Non-Finnish)0.000150.00015rare
South Asian0.000100.000098rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Its binding to fibronectin and some other ligands is calcium dependent. May act as an adapter that mediates the interaction between FBN1 and ELN (PubMed:17255108). {ECO:0000269|PubMed:17255108}.;

Recessive Scores

pRec
0.225

Intolerance Scores

LoFtool
0.0720
RVIS EVS
-1.09
RVIS percentile EVS
6.99

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.586

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.